Opening Bell Analysts Research Calls for Friday, March 17
This report was sent to Briefing.com subscribers earlier today. Research calls posted earlier this morning are available here. Upgrades: > Columbia Banking (COLB) upgraded to Overweight from Neutral at Piper Sandler; tgt $32 > Dr. Reddy’s (RDY) upgraded to Buy…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
This report was sent to Briefing.com subscribers earlier today.
Research calls posted earlier this morning are available here.
Upgrades:
> Columbia Banking (COLB) upgraded to Overweight from Neutral at Piper Sandler; tgt $32
> Dr. Reddy’s (RDY) upgraded to Buy from Neutral at BofA Securities
> SAP SE (SAP) upgraded to Outperform from Neutral at Exane BNP Paribas; tgt $143
Downgrades:
> Bath & Body Works (BBWI) downgraded to Hold from Buy at Argus
> First Republic Bank (FRC) downgraded to Neutral from Overweight at Argus
> Konami Holdings (KNMCY) downgraded to Underperform from Buy at CLSA
> Sage plc (SGPYY) downgraded to Neutral from Outperform at Exane BNP Paribas
> Xero (XROLF) downgraded to Outperform from Buy at CLSA
Others:
> Autolus Therapeutics (AUTL) initiated with a Buy at Bryan Garnier; tgt $5
> Cellectis (CLLS) initiated with a Buy at Bryan Garnier; tgt $6
> CRISPR Therapeutics (CRSP) initiated with a Buy at Bryan Garnier; tgt $70
> FactSet (FDS) initiated with an Outperform at CICC; tgt $500
Contact [email protected] for any questions or corrections.
Paul Ausick has been writing for 247Wallst.com for more than a decade. He has written extensively on investing in the energy, defense, and technology sectors. In a previous life, he wrote technical documentation and managed a marketing communications group in Silicon Valley.
He has a bachelor's degree in English from the University of Chicago and now lives in Montana, where he fishes for trout in the summer and stays inside during the winter.